BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Recipharm Equips Lisbon Facility for US and European Serialisation

  Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines.

  October 23, 2017

   · 

  3 min read
• 

  FDA

  K2M Acquires World’s First & Only FDA-Cleared Cervical Static Corpectomy Cage

  Research supporting favorable findings on the PALO ALTO Cervical Static Corpectomy Cage System to be presented at NASS 2017.

  October 23, 2017

   · 

  9 min read
• Evonik Increases Prices for Potassium Methylate 32% Solution in Methanol

  Evonik Performance Materials GmbH announces a global price increase for its Potassium Methylate solution alkoxide, effective from November 1, 2017.

  October 23, 2017

   · 

  1 min read
• Business

  Pixium Vision Establishes an Equity Line Financing With Kepler Cheuvreux

  Pixium Vision announces the implementation of an equity line financing facility with Kepler Cheuvreux.

  October 23, 2017

   · 

  4 min read
• Pharm Country

  ThyroSeq Presented the Results of its Prospective, Double-Blind, Multi-Center International Study Today, at the 87th Annual Meeting of the ATA in Victoria, BC, Canada

  ThyroSeq presented the results of its prospective, double-blind, multi-center international study today, at the 87th Annual Meeting of the ATA in Victoria, BC, Canada.

  October 23, 2017

   · 

  2 min read
• Deals

  Spero Therapeutics Launches Initial Public Offering

  Spero has also granted the underwriters a 30-day option to purchase an additional 750,000 shares of its common stock.

  October 23, 2017

   · 

  3 min read
• Pluristem Expands its Reach in the Treatment of Impaired Hematopoietic Systems with a European Patent Covering PLX-R18 in Chemotherapy, ARS, Genetic Disorders and Autoimmune Diseases

  Patent significantly expands potential indications for PLX-R18 and grants Pluristem broad coverage in the treatment of damaged hematopoietic systems.

  October 23, 2017

   · 

  5 min read
• Pharming Announces Warrant Exercises and Conversions of Its Ordinary Bonds Into Shares Mostly Through Cashless Exercise

  Pharming Group N.V. announced that since the release of its update regarding cashless and other warrant exercises and bond conversions on 10 August 2017.

  October 23, 2017

   · 

  5 min read
• Biotech Bay

  Natus to be Exclusive U.S. Agent for the First Neonatal MRI Device

  The Embrace Neonatal MRI System is designed specifically for imaging of the neonatal head.

  October 23, 2017

   · 

  2 min read
• Business

  Vical Reports Third Quarter 2017 Financial and Operational Results

  Vical had cash and investments of $35.2 million at September 30, 2017.

  October 23, 2017

   · 

  7 min read